## Clinical Diagnosis: Organophosphate Poisoning with Cholinergic Crisis This patient with known myasthenia gravis has suffered acute organophosphate poisoning, which has precipitated a **cholinergic crisis** — a medical emergency distinct from myasthenic crisis. ### Mechanism: Acetylcholinesterase Inhibition **Key Point:** Organophosphate compounds irreversibly phosphorylate the serine residue in the active site of acetylcholinesterase (AChE), permanently inactivating the enzyme. This causes **massive accumulation of acetylcholine** in all synapses (neuromuscular, autonomic, central). ### Biochemistry of Organophosphate Toxicity 1. **Normal AChE function:** Rapidly hydrolyzes ACh (half-life ~1 ms in synaptic cleft) 2. **Organophosphate binding:** Forms a covalent phosphoryl-enzyme complex 3. **"Aging" process:** Over hours, the phosphoryl-enzyme undergoes dealkylation, becoming irreversible 4. **Result:** ACh accumulates to toxic levels → **depolarization blockade** (see below) ### Pathophysiology: Depolarization Blockade Excess acetylcholine causes: | Phase | Mechanism | Clinical Feature | |-------|-----------|------------------| | **Initial** | Sustained depolarization of motor endplate | Fasciculations (visible muscle twitching) | | **Sustained** | Prolonged depolarization inactivates voltage-gated Na^+^ channels | Flaccid paralysis (paradoxically, despite ACh excess) | | **Result** | Motor endplate cannot repolarize to fire action potentials | Neuromuscular blockade | **High-Yield:** This is called **depolarization blockade** or **phase II block** — a functional neuromuscular blockade caused by excess agonist, not antagonist. ### Clinical Features of Cholinergic Crisis **Mnemonic: SLUDGE + Fasciculations + Respiratory Failure** - **S**alivation (excessive) - **L**acrimation (tearing) - **U**rination (incontinence) - **D**efecation (diarrhea) - **G**astrointestinal upset (nausea, vomiting, cramping) - **E**mesis (vomiting) - **Fasciculations** (visible muscle twitching) - **Miosis** (pinpoint pupils) - **Bradycardia** (muscarinic effect on heart) - **Respiratory failure** (paralysis of diaphragm and intercostal muscles) ### Why This Patient Is in Crisis He has **dual pathology:** 1. Underlying MG: already has reduced safety margin at the NMJ 2. Organophosphate poisoning: acute cholinergic excess The combination is life-threatening. His respiratory rate of 28/min with accessory muscle use indicates impending respiratory failure. ### Distinction: Myasthenic vs. Cholinergic Crisis | Feature | Myasthenic Crisis | Cholinergic Crisis | |---------|-------------------|-------------------| | **Cause** | Insufficient ACh | Excess ACh | | **Pupil size** | Normal | Pinpoint (miosis) | | **Salivation** | Normal | Excessive | | **Fasciculations** | Absent | Present | | **Response to neostigmine** | Improves | Worsens (contraindicated) | | **Atropine** | No effect | Reverses muscarinic signs | **Clinical Pearl:** In a patient with MG presenting with acute weakness, **always check for organophosphate exposure** before giving anticholinesterase drugs. Neostigmine in cholinergic crisis is dangerous — it worsens the blockade. ### Treatment Priorities 1. **Airway protection** (intubation if needed) 2. **Atropine** (muscarinic antagonist) — reverses salivation, bradycardia, bronchospasm 3. **Pralidoxime (2-PAM)** — reactivates AChE if given early (before "aging") 4. **Supportive care** — mechanical ventilation, benzodiazepines for seizures **Warning:** Do NOT give anticholinesterase inhibitors (pyridostigmine, neostigmine) in cholinergic crisis — they will worsen the blockade.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.